The Centre may give sops to drug exporters for shipments to Africa and Latin America through a route that would avoid passing through Europe, while it prepares to drag the EU to the World Trade Organisation (WTO) over seizures of consignments of Indian pharma companies.
The European Union has been seizing Indian generic drugs en route Latin America and Africa citing patent violations.
The Department of Pharmaceuticals has submitted a freight subsidy scheme for exporters to the Commerce Ministry so that they could take alternate routes and avoid transit through Europe, which is a shorter route with better connectivity.
"(The) Ministry of Commerce has agreed with the (subsidy) scheme. I think they will introduce it," Department of Pharmaceuticals Secretary Ashok Kumar told PTI on the sidelines of a FICCI function.
Kumar also said that the government would be taking up the issue of Indian generics drugs seizure by the EU at the WTO.
"We are going to the WTO," Kumar said when asked what the government was doing to help exporters against drugs seizure.
Commenting on the Centre's move, Indian Pharmaceutical Alliance Secretary General D G Shah said: "India should assert the right to free trade and right to passage as per the WTO free trade norms."
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
